sharecast

{{ storiesRelated.title }}

AstraZeneca (AZN)

5,893.00p

13:45 23/04/19

  • 1.34% 78.00p
  • Today's Low & High
  • 5,834.00 / 5,908.00
  • Open / Previous Close
  • 5,858.00 / 5,815.00
  • 52-week range
  • 17.51% 878.00p
  • Volume
  • 1,011,917
  • Market Cap(million)
  • £77,301.73m

5,901.00p REAL TIME BATS

  • 15:02 23/04/19
  • 1.53%
  • 89.00p

KEY FINANCIALS

  Latest Forecast
Div Yield 3.7% 3.7%
Div Cover 1.2 1.3
Op Mrgn 16.1% 23.5%
ROCE 103.5%  
  Latest Forecast
P/E 21.8 22.3
PEG -1.1 12.4
Price / Revenue 4.7 4.2
Price / Book value 7.1  
  Latest Forecast
Revenue 4.5% 4.6%
PBT -10.5% n/a
EPS -19.2% -3.6%
DPS 0.0% 4.9%

KEY FUNDAMENTALS

Year Ending Revenue
($m)		 Pre-tax
($m)		 EPS P/E PEG EPS Growth Div Yield
2014-12-31 26,095.00 1,246.00 $4.28 16.6 -1.1 -15% $2.80 3.9%
2015-12-31 23,641.00 3,069.00 $4.26 16.0 -34.2 0% $2.80 4.1%
2016-12-31 21,319.00 3,552.00 $4.31 12.7 10.8 1% $2.80 5.1%
2017-12-31 20,152.00 2,227.00 $4.28 16.2 -23.2 -1% $2.80 4.0%
2018-12-31 21,049.00 1,993.00 $3.46 21.6 -1.1 -19% $2.80 3.7%

FORECAST

Year Ending Revenue
($m)		 Pre-tax
($m)		 EPS P/E PEG EPS Growth Div Yield
2019-12-31 17,980.79 4,232.75 269.16p 22.3 20.7 1% 215.08p 3.5%
2020-12-31 19,931.39 4,971.30 328.34p 18.5 0.8 22% 217.41p 3.5%

Latest Webfg News

Thursday broker round-up Sharecast News 11 Apr
Wednesday broker round-up Sharecast News 10 Apr
AstraZeneca confirms new EU approval for 'Lynparza' Sharecast News 10 Apr

Regulatory News

Lynparza approved in EU for the treatment of germl 10-Apr-19 07:03
Holding(s) in Company 04-Apr-19 13:31
Director/PDMR Shareholding 03-Apr-19 10:00
Total Voting Rights 02-Apr-19 15:01
Astrazeneca 01-Apr-19 18:00